NCT02093000 2018-02-23
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Hoffmann-La Roche
Completed
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group